Advanced search
Publication Cover
Clinical Toxicology Volume 59, 2021 - Issue 3
Submit an article Journal homepage
642
Views
16
CrossRef citations to date
0
Altmetric
Brief Report

Blood concentrations of synthetic cannabinoids

Piotr AdamowiczDepartment of Forensic Toxicology, Institute of Forensic Research, Kraków, PolandCorrespondence[email protected]
Pages 246-251 | Received 04 Apr 2020, Accepted 19 Jun 2020, Published online: 02 Jul 2020

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

László Institóris, Katalin Kovács, Éva Sija, Róbert Berkecz, Tímea Körmöczi, István Németh, István Elek, Ágnes Bakos, Ildikó Urbán, Csaba Pap & Éva Kereszty. (2022) Clinical symptoms and blood concentration of new psychoactive substances (NPS) in intoxicated and hospitalized patients in the Budapest region of Hungary (2018-19). Clinical Toxicology 60:1, pages 18-24.
Read now
Piotr Adamowicz. (2021) Blood concentrations of synthetic cathinones. Clinical Toxicology 59:7, pages 648-654.
Read now

Articles from other publishers (14)

Jeanna M. Marraffa. 2024. Encyclopedia of Toxicology. Encyclopedia of Toxicology 993 996 .
André Luis Fabris, Aline Franco Martins, Jose Luiz Costa & Mauricio Yonamine. (2023) A new application of the switchable hydrophilicity solvent-based homogenous liquid–liquid microextraction to analyze synthetic cannabinoids in plasma by LC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis 234, pages 115588.
Crossref
Rui Filipe Malheiro, Helena Carmo, Félix Carvalho & João Pedro Silva. (2023) Cannabinoid-mediated targeting of mitochondria on the modulation of mitochondrial function and dynamics. Pharmacological Research 187, pages 106603.
Crossref
Lea Wagmann, Cathy M. Jacobs & Markus R. Meyer. (2022) New Psychoactive Substances: Which Biological Matrix Is the Best for Clinical Toxicology Screening?. Therapeutic Drug Monitoring 44:5, pages 599-605.
Crossref
Sara Malaca, Francesco P. Busardò, Giulio Nittari, Ascanio Sirignano & Giovanna Ricci. (2022) Fourth Generation of Synthetic Cannabinoid Receptor Agonists: A Review on the Latest Insights. Current Pharmaceutical Design 28:32, pages 2603-2617.
Crossref
Adam Worob & Cody J. Wenthur. (2022) Development of Cross-Reactive Antibodies for the Identification and Treatment of Synthetic Cannabinoid Receptor Agonist Toxicity. Vaccines 10:8, pages 1253.
Crossref
Eef L. Theunissen, Johannes T. Reckweg, Nadia R. P. W. Hutten, Kim P. C. Kuypers, Stefan W. Toennes, Merja A. Neukamm, Sebastian Halter & Johannes G. Ramaekers. (2021) Psychotomimetic symptoms after a moderate dose of a synthetic cannabinoid (JWH-018): implications for psychosis. Psychopharmacology 239:5, pages 1251-1261.
Crossref
Piotr Adamowicz & Karolina Nowak. (2021) Blood concentrations of new synthetic opioids. International Journal of Legal Medicine 136:1, pages 107-122.
Crossref
Fabio Vaiano, Elisabetta Bertol, Maria Mineo, Laura Pietrosemoli, Jolanda Rubicondo, Claudiu T. Supuran & Fabrizio Carta. (2021) Development of a New LC-MS/MS Screening Method for Detection of 120 NPS and 43 Drugs in Blood. Separations 8:11, pages 221.
Crossref
Jiahua Ji, Jifen Wang & Ying Zhang. (2021) Rapid screening of 23 synthetic cannabinoids in blood by direct analysis in real time - Tandem mass spectrometry. International Journal of Mass Spectrometry 469, pages 116667.
Crossref
Karolina Nowak & Piotr Adamowicz. (2021) Blood concentrations of new psychoactive substances belonging to benzodiazepine class. Forensic Toxicology 39:2, pages 377-384.
Crossref
Jan-Niklas Kleis, Cornelius Hess, Tanja Germerott & Joerg Roehrich. (2021) Sensitive Screening of New Psychoactive Substances in Serum Using Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry. Journal of Analytical Toxicology.
Crossref
Ayat Zagzoog, Asher L. Brandt, Tallan Black, Eunhyun D. Kim, Riley Burkart, Mikin Patel, Zhiyun Jin, Maria Nikolaeva & Robert B. Laprairie. (2021) Assessment of select synthetic cannabinoid receptor agonist bias and selectivity between the type 1 and type 2 cannabinoid receptor. Scientific Reports 11:1.
Crossref
Andreas BüttnerAndreas Büttner. 2021. Neuropathology of Drug Abuse. Neuropathology of Drug Abuse 23 87 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.